Working… Menu

Phase III Study of Comparing TORIPALIMAB INJECTION Versus Placebo Combined With Chemotherapy for Recurrent or Metastatic Nasophapyngeal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03581786
Recruitment Status : Completed
First Posted : July 10, 2018
Last Update Posted : January 25, 2021
Information provided by (Responsible Party):
Shanghai Junshi Bioscience Co., Ltd.